日期 影响因子
日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:
–

Favorable Activity and Safety Profile of Memory-Enriched CD19-Targeted Chimeric Antigen Receptor T-Cell Therapy in Adults with High-Risk Relapsed/Refractory ALL

记忆富集型CD19靶向嵌合抗原受体T细胞疗法在成人高危复发/难治性ALL患者中展现出良好的活性和安全性

期刊:Clinical Cancer Research
影响因子:10.2
doi:10.1158/1078-0432.CCR-22-2038
Aldoss, Ibrahim; Khaled, Samer K; Wang, Xiuli; Palmer, Joycelynne; Wang, Yan; Wagner, Jamie R; Clark, Mary C; Simpson, Jennifer; Paul, Jinny; Vyas, Vibhuti; Chien, Sheng-Hsuan; Stein, Anthony; Pullarkat, Vinod; Salhotra, Amandeep; Al Malki, Monzr M; Aribi, Ahmed; Sandhu, Karamjeet; Thomas, Sandra H; Budde, Lihua E; Marcucci, Guido; Brown, Christine E; Forman, Stephen J
T细胞
信号转导
T细胞
细胞生物学
CD19
免疫/内分泌
发表日期：2023
文献求助 收藏

Anti-CD25 radioimmunotherapy with BEAM autologous hematopoietic cell transplantation conditioning in Hodgkin lymphoma

霍奇金淋巴瘤采用抗CD25放射免疫疗法联合BEAM自体造血干细胞移植预处理

期刊:Blood Advances
影响因子:7.1
doi:10.1182/bloodadvances.2021004981
Herrera, Alex F; Palmer, Joycelynne; Adhikarla, Vikram; Yamauchi, Dave; Poku, Erasmus K; Bading, James; Yazaki, Paul; Dandapani, Savita; Mei, Matthew; Chen, Robert; Cao, Thai; Karras, Nicole; McTague, Pamela; Nademanee, Auayporn; Popplewell, Leslie; Sahebi, Firoozeh; Shively, John E; Simpson, Jennifer; Smith, D Lynne; Song, Joo; Spielberger, Ricardo; Tsai, Ni-Chun; Thomas, Sandra H; Forman, Stephen J; Colcher, David; Wu, Anna M; Wong, Jeffrey; Smith, Eileen
干细胞
CD25
发育与干细胞
免疫/内分泌
CD2
淋巴瘤
细胞生物学
发表日期：2021
文献求助 收藏

Lenalidomide Enhances the Function of CS1 Chimeric Antigen Receptor-Redirected T Cells Against Multiple Myeloma.

来那度胺增强 CS1 嵌合抗原受体重定向 T 细胞对抗多发性骨髓瘤的功能

期刊:Clinical Cancer Research
影响因子:10.2
doi:10.1158/1078-0432.CCR-17-0344
Wang Xiuli, Walter Miriam, Urak Ryan, Weng Lihong, Huynh Christian, Lim Laura, Wong ChingLam W, Chang Wen-Chung, Thomas Sandra H, Sanchez James F, Yang Lu, Brown Christine E, Pichiorri Flavia, Htut Myo, Krishnan Amrita Y, Forman Stephen J
细胞生物学
发表日期：2018
文献求助 收藏

Phase I Trial of Total Marrow and Lymphoid Irradiation Transplantation Conditioning in Patients with Relapsed/Refractory Acute Leukemia

复发/难治性急性白血病患者接受全骨髓和淋巴照射移植预处理的I期试验

期刊:Biology of Blood and Marrow Transplantation
影响因子:
doi:10.1016/j.bbmt.2017.01.067
Stein, Anthony; Palmer, Joycelynne; Tsai, Ni-Chun; Al Malki, Monzr M; Aldoss, Ibrahim; Ali, Haris; Aribi, Ahmed; Farol, Len; Karanes, Chatchada; Khaled, Samer; Liu, An; O'Donnell, Margaret; Parker, Pablo; Pawlowska, Anna; Pullarkat, Vinod; Radany, Eric; Rosenthal, Joseph; Sahebi, Firoozeh; Salhotra, Amandeep; Sanchez, James F; Schultheiss, Tim; Spielberger, Ricardo; Thomas, Sandra H; Snyder, David; Nakamura, Ryotaro; Marcucci, Guido; Forman, Stephen J; Wong, Jeffrey
白血病
发表日期：2017
文献求助 收藏

Phase 1 studies of central memory-derived CD19 CAR T-cell therapy following autologous HSCT in patients with B-cell NHL

在B细胞非霍奇金淋巴瘤患者中，自体造血干细胞移植后采用中央记忆来源的CD19 CAR T细胞疗法的I期研究

期刊:Blood
影响因子:23.1
doi:10.1182/blood-2015-12-686725
Wang, Xiuli; Popplewell, Leslie L; Wagner, Jamie R; Naranjo, Araceli; Blanchard, M Suzette; Mott, Michelle R; Norris, Adam P; Wong, ChingLam W; Urak, Ryan Z; Chang, Wen-Chung; Khaled, Samer K; Siddiqi, Tanya; Budde, Lihua E; Xu, Jingying; Chang, Brenda; Gidwaney, Nikita; Thomas, Sandra H; Cooper, Laurence J N; Riddell, Stanley R; Brown, Christine E; Jensen, Michael C; Forman, Stephen J
B细胞
发育与干细胞
T细胞
淋巴瘤
T细胞
干细胞
细胞生物学
CD19
免疫/内分泌
发表日期：2016
文献求助 收藏

Influence of Absorption, Distribution, Metabolism, and Excretion Genomic Variants on Tacrolimus/Sirolimus Blood Levels and Graft-versus-Host Disease after Allogeneic Hematopoietic Cell Transplantation

吸收、分布、代谢和排泄基因组变异对同种异体造血干细胞移植后他克莫司/西罗莫司血药浓度和移植物抗宿主病的影响

期刊:Biology of Blood and Marrow Transplantation
影响因子:
doi:10.1016/j.bbmt.2015.08.027
Khaled, Samer K; Palmer, Joycelynne M; Herzog, Josef; Stiller, Tracey; Tsai, Ni-Chun; Senitzer, David; Liu, Xueli; Thomas, Sandra H; Shayani, Sepideh; Weitzel, Jeffrey; Forman, Stephen J; Nakamura, Ryotaro
代谢
发育与干细胞
细胞生物学
干细胞
发表日期：2016
文献求助 收藏

A phase II study of vorinostat and rituximab for treatment of newly diagnosed and relapsed/refractory indolent non-Hodgkin lymphoma

一项评估伏立诺他联合利妥昔单抗治疗新诊断和复发/难治性惰性非霍奇金淋巴瘤的II期临床研究

期刊:Haematologica
影响因子:7.9
doi:10.3324/haematol.2014.117473
Chen, Robert; Frankel, Paul; Popplewell, Leslie; Siddiqi, Tanya; Ruel, Nora; Rotter, Arnold; Thomas, Sandra H; Mott, Michelle; Nathwani, Nitya; Htut, Myo; Nademanee, Auayporn; Forman, Stephen J; Kirschbaum, Mark
淋巴瘤
发表日期：2015
文献求助 收藏

CD30 Downregulation, MMAE Resistance, and MDR1 Upregulation Are All Associated with Resistance to Brentuximab Vedotin

CD30 下调、MMAE 耐药和 MDR1 上调均与 Brentuximab Vedotin 耐药相关。

期刊:Molecular Cancer Therapeutics
影响因子:5.5
doi:10.1158/1535-7163.MCT-15-0036
Chen, Robert; Hou, Jessie; Newman, Edward; Kim, Young; Donohue, Cecile; Liu, Xueli; Thomas, Sandra H; Forman, Stephen J; Kane, Susan E
CD3
CD30
多发性骨髓瘤
发表日期：2015
文献求助 收藏

Brentuximab vedotin is associated with improved progression-free survival after allogeneic transplantation for Hodgkin lymphoma

Brentuximab vedotin 与霍奇金淋巴瘤异基因移植后无进展生存期的改善相关

期刊:Biology of Blood and Marrow Transplantation
影响因子:
doi:10.1016/j.bbmt.2014.06.037
Chen, Robert; Palmer, Joycelynne M; Tsai, Ni-Chun; Thomas, Sandra H; Siddiqi, Tanya; Popplewell, Leslie; Farol, Len; Nademanee, Auayporn; Forman, Stephen J
淋巴瘤
发表日期：2014
文献求助 收藏

Late relapses following reduced intensity allogeneic transplantation in patients with multiple myeloma: a long-term follow-up study

多发性骨髓瘤患者接受减低强度异基因移植后的晚期复发：一项长期随访研究

期刊:British Journal of Haematology
影响因子:3.8
doi:10.1111/bjh.12123
Sahebi, Firoozeh; Shen, Yan; Thomas, Sandra H; Rincon, Amalia; Murata-Collins, Joyce; Palmer, Joycelynne; Krishnan, Amrita Y; Karanes, Chatchada; Htut, Myo; Somlo, George; Forman, Stephen J
多发性骨髓瘤
骨髓瘤
发表日期：2013
文献求助 收藏